Novel strategy for oral peptide delivery in incretin-based diabetes treatment.

Although this reduction compared with the HFD group did not reach statistical significance when the data were analysed by the Kruskal-Wallis followed by Dunn’s post hoc test ( figure 3B ), a significant difference was found when analysed by the Mann-Whitney test (p=0.04 for EXE-RM-LNC vs HFD).

also in 111,027 other papers

Our data point to a strong trend towards lower key markers associated with infiltration-recruitment of immune cell populations (macrophages, dendritic cells) and inflammatory markers in both the liver and VAT, again highlighting the beneficial effects of our approach on such markers.

also in 5,725 other papers